| Bioactivity | TYRA-300 GMP is TYRA-300 (HY-159642) produced by using GMP guidelines. TYRA-300 GMP is an orally active, selective inhibitor for FGFR3 with an IC50 of 11 nM. TYRA-300 GMP exhibits antitumor efficacy against urothelial cancers and solid tumors[1]. |
| CAS | 2800223-30-5 |
| Formula | C25H24Cl2N6O3S |
| Molar Mass | 559.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Hudkins RL, et al., Discovery of TYRA-300: First Oral Selective FGFR3 Inhibitor for the Treatment of Urothelial Cancers and Achondroplasia. J Med Chem. 2024 Sep 26;67(18):16737-16756. |
TYRA-300
CAS: 2800223-30-5 F: C25H24Cl2N6O3S W: 559.47
TYRA-300 GMP is TYRA-300 (HY-159642) produced by using GMP guidelines. TYRA-300 GMP is an orally active, selective inhib
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.